Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 3/20 | 0.36 |
| ▸ | TACR2 | P21452 | 2/20 | 0.32 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.32 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.32 |
| ▸ | BCHE | P06276 | 2/20 | 0.31 |
| ▸ | ACHE | P22303 | 2/20 | 0.31 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.31 |
| ▸ | CDK1 | P06493 | 1/20 | 0.31 |
| ▸ | CDK4 | P11802 | 1/20 | 0.31 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.31 |
| ▸ | CCND1 | P24385 | 1/20 | 0.31 |
| ▸ | CCNB3 | Q8WWL7 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13425526 | 1.00 | ERN1 (0.36) | ERN1TACR2FFAR4MCL1BCHE | |
| SCHEMBL589371 | 1.00 | ERN1 (0.36) | ERN1TACR2FFAR4MCL1BCHE | |
| SCHEMBL3217631 | 0.86 | MAOB (0.31) | FFAR4ALDH1A1SMN1; SMN2 | |
| SCHEMBL3217642 | 0.86 | MAOB (0.31) | FFAR4ALDH1A1SMN1; SMN2 | |
| SCHEMBL3224921 | 0.85 | SLC5A2 (0.35) | TACR2FFAR4 | |
| SCHEMBL3224932 | 0.85 | SLC5A2 (0.35) | TACR2FFAR4 | |
| SCHEMBL3220448 | 0.84 | ABCB1 (0.36) | — | |
| SCHEMBL3220459 | 0.84 | ABCB1 (0.36) | — | |
| SCHEMBL590554 | 0.83 | TACR2 (0.31) | TACR2BCHEACHESMN1; SMN2 | |
| SCHEMBL590553 | 0.83 | TACR2 (0.31) | TACR2BCHEACHESMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2036901-B1 | C-PHENYL 1-THIOGLUCITOL COMPOUND | TAISHO PHARMACEUTICAL CO LTD (JP) | 2013-05-01 | — | — | EP | disclosed |
| US-8115017-B2 | C-phenyl 1-thioglucitol compound | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2012-02-14 | — | — | US | disclosed |
| US-20100069460-A1 | 1-PHENYL 1-THIO-D-GLUCITOL DERIVATIVE | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2010-03-18 | — | — | US | disclosed |
| US-20100004465-A1 | C-PHENYL 1-THIOGLUCITOL COMPOUND | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2010-01-07 | — | — | US | disclosed |
| EP-2103607-A1 | 1-PHENYL 1-THIO-D-GLUCITOL DERIVATIVE | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2009-09-23 | — | — | EP | disclosed |
| EP-2036901-A1 | C-PHENYL 1-THIOGLUCITOL COMPOUND | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2009-03-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100004465-A1 | C-PHENYL 1-THIOGLUCITOL COMPOUND | SLC5A1, SLC5A2, SLC2A1 | ERN1 2518/4885TACR2 978/4885FFAR4 2727/4885 |
| US-20100069460-A1 | 1-PHENYL 1-THIO-D-GLUCITOL DERIVATIVE | SLC5A1, SLC5A2, SLC2A1 | ERN1 2673/4885TACR2 2521/4885FFAR4 1498/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.